Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New synthetic process for swainsonine should facilitate clinical testing

Nov. 1, 1996

Hybridon questions role of CAPL in cancer metastasis

Nov. 1, 1996

Low-toxicity antitumor agents described by Ajinomoto

Nov. 1, 1996

Antitumor organotin compounds claimed by Dutch company

Nov. 1, 1996

Peregrine seeks partners for development of vascular targeting agents

Nov. 1, 1996

Cell adhesion inhibitors reported by Sumitomo

Nov. 1, 1996

PDL signs humanized antibody agreement with Japanese company

Nov. 1, 1996

First gene gun clinical trial announced by Auragen

Nov. 1, 1996

HHS claims MAb for therapeutic, diagnostic and immunologic applications

Nov. 1, 1996

Antitumor antibody for medulloblastoma Rx claimed by Chugai

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...